CD274 and neoplasm: The results indicate that the recombinant hsCD80 expressed from L‐hsCD80 may directly act on tumor cells and immune cells in the intestinal mucosa and restore cytotoxic T cell (TCL) activity by blocking PDL1/PD‐1 binding, resulting in a good antitumor effect.